Grape King Bio Ltd (TPE:1707)

Grape King Bio Revenue

Grape King Bio had revenue of 2.41B TWD in the quarter ending June 30, 2026, a decrease of -6.05%. This brings the company's total for the last twelve months to 10.12B, down -6.93% year-over-year. In the year 2025, Grape King Bio had annual revenue of 10.25B, down -8.14%. That makes Grape King Bio the 14,298th largest company in the world by revenue and 449th in Taiwan.

• Revenue (ttm): 10.12B
• Revenue Growth: -6.93%
• P/S Ratio: 1.26
• Revenue / Employee: 20.20M
• Employees: 501
• Market Cap: 12.68B

Revenue Chart

Chart

Chart

Revenue by Segment

By Segment

Chart

• MLM 9.44B 78.2%
• ODM/OEM 1.08B 9.0%
• Distribution Department 899.22M 7.5%
• Sales Channel 642.73M 5.3%

By Geography

Chart

• Taiwan 9.09B 88.6%
• Mainland China 1.01B 9.9%
• Other 153.57M 1.5%

Fiscal year ended Dec 31, 2025 See the full Grape King Bio breakdown

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	10.25B	-908.40M	-8.14%
Dec 31, 2024	11.16B	524.54M	4.93%
Dec 31, 2023	10.64B	244.23M	2.35%
Dec 31, 2022	10.39B	592.99M	6.05%
Dec 31, 2021	9.80B	630.05M	6.87%

Data Source: S&P Global Market Intelligence Last updated: Aug 27, 2026

Revenue data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Oct 19, 2026

Data Sources Report a data error